Persistent SARS-CoV-2 Infection in a Multiple Sclerosis Patient on Ocrelizumab: A Case Report

A 44-year-old female patient with multiple sclerosis (MS) treated with ocrelizumab was hospitalized with SARS-CoV-2 pneumonia three times over the course of five months, eventually expiring. Viral sequencing of samples from her first and last admissions suggests a single persistent SARS-CoV-2 infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambadapoodi, Raghava S., Arnold, Forest W., Chariker, Julia H., Glynn, Alex, Lauer, William, Marimuthu, Subathra, Rouchka, Eric C., Smith, Melissa L., Wolf, Leslie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104259/
https://www.ncbi.nlm.nih.gov/pubmed/37066424
http://dx.doi.org/10.21203/rs.3.rs-2768759/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104259/
https://www.ncbi.nlm.nih.gov/pubmed/37066424
http://dx.doi.org/10.21203/rs.3.rs-2768759/v1

Ejemplares similares